CN113648376A - Plaster for treating mastitis of dairy goat and preparation method thereof - Google Patents
Plaster for treating mastitis of dairy goat and preparation method thereof Download PDFInfo
- Publication number
- CN113648376A CN113648376A CN202111123546.2A CN202111123546A CN113648376A CN 113648376 A CN113648376 A CN 113648376A CN 202111123546 A CN202111123546 A CN 202111123546A CN 113648376 A CN113648376 A CN 113648376A
- Authority
- CN
- China
- Prior art keywords
- parts
- plaster
- radix
- mastitis
- type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a plaster for treating mastitis of a milk goat and a preparation method thereof, belonging to the technical field of veterinary drugs, and the plaster comprises the following raw materials: realgar, phellodendron, borneol, madder, rhubarb, dandelion, bletilla, keel, ampelopsis japonica, pseudo-ginseng, astragalus and skin penetrant; the raw materials of the invention include realgar and phellodendron bark for detoxification and sore treatment; borneol has the effects of relieving swelling and pain; rhubarb has the effects of clearing heat, relieving swelling, removing blood stasis and stimulating the menstrual flow; radix Rubiae has effects of cooling blood, promoting blood circulation, removing blood stasis, and dredging channels; the dandelion powder has the functions of clearing away heat and toxic material, and relieving pain and stopping pain; notoginseng radix has effects in promoting blood circulation, dispelling blood stasis, relieving pain, and relieving swelling; radix astragali, rhizoma Bletillae, radix Angelicae Dahuricae, radix Ampelopsis, and Os Draconis have effects of relieving swelling and promoting granulation. The traditional Chinese medicine is used together, has the effects of clearing away heat and toxic materials, reducing swelling and dissipating blood stasis, can increase the permeability and the drug absorption of the skin by matching with a skin penetrating agent, accelerates the transmission and the blood circulation of the drug, has no stimulation to animals, has no influence on dairy products, and has obvious effect on treating mastitis.
Description
Technical Field
The invention belongs to the technical field of veterinary medicines, and particularly relates to a plaster for treating mastitis of a milk goat and a preparation method thereof.
Background
Mastitis is the most common disease in the frequently encountered diseases of the milk goat ewes, and is also a disease with relatively high hazard. The occurrence of mastitis can not only cause the reduction of the yield and the quality of milk sources, but also increase the breeding cost and the medical expense, cause huge economic loss to the dairy industry, influence the quality of raw milk and mutton, promote the growth of harmful microorganisms, cause food safety problems and harm human health.
The current treatment method for the mastitis of the dairy goats comprises the following steps: the method comprises the steps of intramuscular injection of antibiotics, local injection of antibiotics, and drenching of Chinese herbal medicines or antibiotics, wherein the method has the drug residues, and after the antibiotics are locally used (breast injection), substantial lesions can be formed on a focus area, so that the milk yield after diseases is greatly reduced, and the production performance is difficult to recover; the intramuscular or intravenous injection of antibiotics can cause the residual time of antibiotics in the organism to be overlong, generally 7 to 10 days, and the recurrence rate after illness is higher; the traditional Chinese medicine irrigation is difficult to operate, particularly, the air inlet pipe is easily caused to be irrigated, foreign pneumonia even death is caused, and physical damage can occur due to irrigation stress in individual cases.
Disclosure of Invention
The invention aims to provide a plaster for treating mastitis of a milk goat and a preparation method thereof, and solves the problems in the prior art.
The purpose of the invention can be realized by the following technical scheme:
a preparation method of a plaster for treating mastitis of a milk goat comprises the following steps:
firstly, weighing raw materials in parts by weight; cutting radix Rubiae, radix et rhizoma Rhei, herba Taraxaci, rhizoma Bletillae, radix Ampelopsis, Notoginseng radix and radix astragali into small segments, mashing, soaking in edible oil for three days, heating, controlling oil temperature at 220 deg.C until the surface of the medicinal materials turns black and the inner part is brown, removing residue, and keeping medicinal oil; grinding realgar, phellodendron and keel and sieving by a 100-mesh sieve for later use;
heating the medicinal oil to 320-;
thirdly, soaking the obtained ointment in cold water for 3 days, and changing water for 2 times every day; taking out the soaked ointment, drying, re-melting, adding borneol and skin penetrant, uniformly mixing, rolling the ointment with bamboo chopsticks, taking paper cloth, spreading the ointment on the I type medicine area or the II type medicine area on the paper cloth clockwise by pointing the center of the paper cloth with the bamboo chopsticks, and cooling to obtain the plaster for treating the mastitis of the milch goat.
Further, the edible oil is one of soybean oil, rapeseed oil and tea oil.
Further, paper cloth is divided into type i and type ii, type i: the width of the upper top is 30 cm, the total height is 40 cm, the diameter and the length of the blank area are 5 cm, and the width of the I-type adhesive area is 1 cm; type II: the overall diameter was 5 cm, with the type II drug region having a diameter of 4 cm and the type II viscose region having a width of 1 cm.
A plaster for treating mastitis of a milk goat comprises the following raw materials in parts by weight:
10-12 parts of realgar, 50-55 parts of golden cypress, 5-6 parts of borneol, 22-24 parts of madder, 20-24 parts of rhubarb, 100 parts of dandelion, 20-24 parts of bletilla striata, 20-24 parts of keel, 20-22 parts of ampelopsis japonica, 10-12 parts of pseudo-ginseng, 35-38 parts of astragalus mongholicus and 75-80 parts of skin penetrant;
further, the skin penetrating agent is N-N-alkyl benzisothiazolone.
Further, the adhesives used in the type i and type ii adhesive zones are prepared by the following steps:
step S11, mixing carboxymethyl chitosan and deionized water, adding 2, 3-epoxypropyltrimethylammonium chloride, stirring and reacting for 24 hours at the temperature of 60 ℃, precipitating with absolute ethyl alcohol after the reaction is finished, centrifugally washing the precipitate with deionized water, and drying in vacuum to constant weight after the washing is finished to obtain an antibacterial component;
and step S12, mixing isophorone diisocyanate, an antibacterial component and butanone, then adding dibutyltin dilaurate, adding a mixed solution of an amine chain extender and butanone under the protection of nitrogen at the temperature of 80 ℃, stirring for reacting for 2 hours, removing the solvent through decompression, and discharging to obtain a crude product. And (4) transferring the crude product to a vacuum drying oven, and performing vacuum drying for 24h to obtain the adhesive. The common pressure-sensitive adhesive has extremely poor water vapor permeability and oxygen permeability, and can cause water accumulation on skin to whiten the skin after long-term use, and is often accompanied with allergy.
Further, in step S11, the ratio of the carboxymethyl chitosan to the 2, 3-epoxypropyltrimethylammonium chloride to the deionized water is 1 g: 20mL of: 80 mg; in the step S12, the amine chain extender is one of ethylenediamine and diethylenediamine; the mixed solution of the amine chain extender and butanone is prepared from the following components in a ratio of 1 g: 10mL of the mixture is mixed; the using amount ratio of isophorone diisocyanate, antibacterial component, butanone, dibutyltin dilaurate and amine chain extender is 20 g: 12 g: 200mL of: 0.5 g: 6 g.
The invention has the beneficial effects that:
the raw materials of the invention include realgar and phellodendron bark for detoxification and sore treatment; borneol has the effects of relieving swelling and pain; rhubarb has the effects of clearing heat, relieving swelling, removing blood stasis and stimulating the menstrual flow; radix Rubiae has effects of cooling blood, promoting blood circulation, removing blood stasis, and dredging channels; the dandelion powder has the functions of clearing away heat and toxic material, and relieving pain and stopping pain; notoginseng radix has effects in promoting blood circulation, dispelling blood stasis, relieving pain, and relieving swelling; radix astragali, rhizoma Bletillae, radix Angelicae Dahuricae, radix Ampelopsis, and Os Draconis have effects of relieving swelling and promoting granulation. The traditional Chinese medicine is used together, has the effects of clearing away heat and toxic materials, reducing swelling and dissipating blood stasis, can increase the permeability and drug absorption of the skin by matching with a skin penetrating agent, stimulates nerve endings to enhance the body circulation, accelerates the transmission and the blood circulation of the drug, can be absorbed by a body more quickly, is externally applied by the Chinese herbal medicines, has no stimulation to animals, has no influence on dairy products, is beneficial to relieving the pain feeling of the animals, repairs mammary glands, is beneficial to the recovery of the production performance after diseases, is not influenced, and has obvious effect on treating mastitis.
Drawings
In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings used in the description of the embodiments will be briefly introduced below, and it is obvious that the drawings in the following description are only some embodiments of the present invention, and it is obvious for those skilled in the art that other drawings can be obtained according to the drawings without creative efforts.
FIG. 1 is a schematic structural diagram of a type I paper cloth in a plaster for treating mastitis of a milk goat;
FIG. 2 is a schematic structural diagram of type II paper cloth in the plaster for treating mastitis of milk goats;
in the drawings, the components represented by the respective reference numerals are listed below:
1. a type i drug region; 2. a type I viscose zone; 3. a blank area; 4. a type II drug region; 5. type II viscose area.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
Preparing an adhesive:
step S11, mixing carboxymethyl chitosan and deionized water, adding 2, 3-epoxypropyltrimethylammonium chloride, stirring and reacting for 24 hours at the temperature of 60 ℃, precipitating with absolute ethyl alcohol after the reaction is finished, centrifugally washing the precipitate with deionized water, and drying in vacuum to constant weight after the washing is finished to obtain an antibacterial component; wherein the dosage ratio of the carboxymethyl chitosan, the 2, 3-epoxypropyl trimethyl ammonium chloride and the deionized water is 1 g: 20mL of: 80 mg;
and step S12, mixing isophorone diisocyanate, an antibacterial component and butanone, then adding dibutyltin dilaurate, adding a mixed solution of an amine chain extender and butanone under the protection of nitrogen at the temperature of 80 ℃, stirring for reacting for 2 hours, removing the solvent through decompression, and discharging to obtain a crude product. Transferring the crude product into a vacuum drying oven, and carrying out vacuum drying for 24h to obtain an adhesive; wherein the amine chain extender is one of ethylenediamine and diethylenediamine; the mixed solution of the amine chain extender and butanone is prepared from the following components in a ratio of 1 g: 10mL of the mixture is mixed; the using amount ratio of isophorone diisocyanate, antibacterial component, butanone, dibutyltin dilaurate and amine chain extender is 20 g: 12 g: 200mL of: 0.5 g: 6 g.
Example 2
Firstly, weighing raw materials in parts by weight; cutting radix Rubiae, radix et rhizoma Rhei, herba Taraxaci, rhizoma Bletillae, radix Ampelopsis, Notoginseng radix and radix astragali into small segments, mashing, soaking in edible oil for three days, heating, controlling oil temperature at 220 deg.C until the surface of the medicinal materials turns black and the inner part is brown, removing residue, and keeping medicinal oil; grinding realgar, phellodendron and keel and sieving by a 100-mesh sieve for later use;
heating the medicinal oil to 310 ℃, adding realgar, golden cypress and keel, simultaneously stirring clockwise, dipping the ointment in a pot with bamboo chopsticks when smoke is not emitted any more and the ointment is a black oil paste, dripping cold water into the ointment, enabling the ointment on the water surface to be bead-shaped and not to be scattered, taking out the beads, wiping the surface moisture, trying to pinch with dry hands, stopping the fire when the beads are stuck to the hands and are not greasy when the beads are separated from the hands, and continuously stirring until the ointment is cooled to room temperature after the fire is stopped;
thirdly, soaking the obtained ointment in cold water for 3 days, and changing water for 2 times every day; taking out the soaked ointment, air drying, re-melting, adding Borneolum Syntheticum and skin penetrating agent, and mixing to obtain ointment;
wherein the edible oil is one of soybean oil, rapeseed oil and tea oil; the weight portions of the raw materials are: 10 parts of realgar, 50 parts of phellodendron, 5 parts of borneol, 22 parts of madder, 20 parts of rhubarb, 100 parts of dandelion, 20 parts of bletilla, 20 parts of keel, 20 parts of ampelopsis japonica, 10 parts of pseudo-ginseng, 35 parts of astragalus mongholicus and 75 parts of skin penetrant; the skin penetrating agent is N-N-alkyl benzisothiazolinone.
Example 3
Firstly, weighing raw materials in parts by weight; cutting radix Rubiae, radix et rhizoma Rhei, herba Taraxaci, rhizoma Bletillae, radix Ampelopsis, Notoginseng radix and radix astragali into small segments, mashing, soaking in edible oil for three days, heating, controlling oil temperature at 220 deg.C until the surface of the medicinal materials turns black and the inner part is brown, removing residue, and keeping medicinal oil; grinding realgar, phellodendron and keel and sieving by a 100-mesh sieve for later use;
heating the medicinal oil to 315 ℃, adding realgar, golden cypress and keel, simultaneously stirring clockwise, dipping the ointment in a pot with bamboo chopsticks when smoke is not emitted any more and the ointment is a black oil paste, dripping cold water into the ointment, enabling the ointment on the water surface to be bead-shaped and not to be scattered, taking out the beads, wiping the surface moisture, trying to pinch with dry hands, stopping the fire when the beads are stuck to the hands and are not greasy when the beads are separated from the hands, and continuously stirring until the ointment is cooled to room temperature after the fire is stopped;
thirdly, soaking the obtained ointment in cold water for 3 days, and changing water for 2 times every day; taking out the soaked ointment, air drying, re-melting, adding Borneolum Syntheticum and skin penetrating agent, and mixing to obtain ointment;
wherein the edible oil is one of soybean oil, rapeseed oil and tea oil; the weight portions of the raw materials are: 11 parts of realgar, 52 parts of golden cypress, 5 parts of borneol, 23 parts of madder, 22 parts of rheum officinale, 105 parts of dandelion, 22 parts of bletilla striata, 22 parts of keel, 21 parts of ampelopsis japonica, 11 parts of pseudo-ginseng, 36 parts of astragalus mongholicus and 78 parts of skin penetrant; the skin penetrating agent is N-N-alkyl benzisothiazolinone.
Example 4
Firstly, weighing raw materials in parts by weight; cutting radix Rubiae, radix et rhizoma Rhei, herba Taraxaci, rhizoma Bletillae, radix Ampelopsis, Notoginseng radix and radix astragali into small segments, mashing, soaking in edible oil for three days, heating, controlling oil temperature at 220 deg.C until the surface of the medicinal materials turns black and the inner part is brown, removing residue, and keeping medicinal oil; grinding realgar, phellodendron and keel and sieving by a 100-mesh sieve for later use;
heating the medicinal oil to 320 ℃, adding realgar, golden cypress and keel, simultaneously stirring clockwise, dipping the ointment in a pot with bamboo chopsticks when smoke is not emitted any more and the ointment is a black oil paste, dripping cold water into the ointment, enabling the ointment on the water surface to be bead-shaped and not to be scattered, taking out the beads, wiping the surface moisture, trying to pinch with dry hands, stopping the fire when the beads are stuck to the hands and are not greasy when the beads are separated from the hands, and continuously stirring until the ointment is cooled to room temperature after the fire is stopped;
thirdly, soaking the obtained ointment in cold water for 3 days, and changing water for 2 times every day; taking out the soaked ointment, air drying, re-melting, adding Borneolum Syntheticum and skin penetrating agent, and mixing to obtain ointment;
wherein the edible oil is one of soybean oil, rapeseed oil and tea oil; the weight portions of the raw materials are: 12 parts of realgar, 55 parts of golden cypress, 6 parts of borneol, 24 parts of madder, 24 parts of rhubarb, 110 parts of dandelion, 24 parts of bletilla striata, 24 parts of keel, 22 parts of Japanese ampelopsis root, 12 parts of pseudo-ginseng, 38 parts of astragalus and 80 parts of skin penetrating agent; the skin penetrating agent is N-N-alkyl benzisothiazolinone.
Referring to fig. 1-2, the paper cloth is classified into types i and ii, wherein type i: the width of the upper top is 30 cm, the total height is 40 cm, the diameter and the length of the blank area 3 are 5 cm, two I-type medicine areas 1 which are symmetrical about the blank area 3 are arranged, and the width of the I-type viscose area 2 is 1 cm; the teat of the milk goat may pass through the blank area 3.
Type II: the overall shape is circular with a diameter of 5 cm, with type ii drug region 4 having a diameter of 4 cm and type ii viscose region 5 having a width of 1 cm.
Example 5
The ointment prepared in the embodiment 2 is rolled up by bamboo chopsticks, paper cloth is taken, and the ointment is respectively spread in the I-type medicine area 1 and the II-type medicine area 4 clockwise by pointing the bamboo chopsticks at the center of the paper cloth; cooling to obtain a plaster for treating the mastitis of the dairy goat; the adhesive prepared in example 1 was melt-coated on the type i adhesive region 2 and the type ii adhesive region 5.
Example 6
The ointment prepared in the embodiment 3 is rolled up by bamboo chopsticks, paper cloth is taken, and the ointment is respectively spread in the I-type medicine area 1 and the II-type medicine area 4 clockwise by pointing the bamboo chopsticks at the center of the paper cloth; cooling to obtain a plaster for treating the mastitis of the dairy goat; the adhesive prepared in example 1 was melt-coated on the type i adhesive region 2 and the type ii adhesive region 5.
Example 7
The ointment prepared in the embodiment 4 is rolled up by bamboo chopsticks, paper cloth is taken, and the ointment is respectively spread in the I-type medicine area 1 and the II-type medicine area 4 clockwise by pointing the bamboo chopsticks at the center of the paper cloth; cooling to obtain a plaster for treating the mastitis of the dairy goat; the adhesive prepared in example 1 was melt-coated on the type i adhesive region 2 and the type ii adhesive region 5.
The plasters prepared in examples 5 to 7 were subjected to an anti-inflammatory test;
40 Kunming white mice were randomly divided into 4 groups of 10 mice each. The control group was not treated; experimental groups: the plasters prepared in examples 5-7 were applied to the left ear of the mouse, and the right ear was used as its control. And 1h after the last administration, the medicine is washed with distilled water and wiped dry with a dry cotton ball. 0.02mL of dimethylbenzene is dripped into and out of the left ear to cause inflammation, the cervical vertebra of the mouse is dislocated and killed after the inflammation is caused for 1h, double ears are cut at the base of the auricle, round lugs are taken down at the symmetrical positions of the left ear and the right ear by a puncher with the diameter of 0.6cm, the round lugs are weighed, and the weight difference of the left ear and the right ear is used as swelling degree. The inhibition rate of inflammatory swelling was calculated.
The inflammatory swelling inhibition (%) was 1- (difference in the weight of the left and right ear of the drug group/the weight of the left and right ear of the control group);
examples 5-7 had inhibition rates of 59.6%, 60.1% and 59.3%, respectively.
The plaster prepared in the embodiment 6 is applied to the mastitis of the milk goat, firstly, the breast of the milk goat is cleaned, and the long hair is removed, so that the plaster can be directly contacted with the skin conveniently. The medicine is replaced every 24 hours, is continuously used for three days, and has obvious improvement effect on mastitis after being used.
In the description herein, references to the description of "one embodiment," "an example," "a specific example" or the like are intended to mean that a particular feature, structure, material, or characteristic described in connection with the embodiment or example is included in at least one embodiment or example of the invention. In this specification, the schematic representations of the terms used above do not necessarily refer to the same embodiment or example. Furthermore, the particular features, structures, materials, or characteristics described may be combined in any suitable manner in any one or more embodiments or examples.
The foregoing is merely exemplary and illustrative of the principles of the present invention and various modifications, additions and substitutions of the specific embodiments described herein may be made by those skilled in the art without departing from the principles of the present invention or exceeding the scope of the claims set forth herein.
Claims (7)
1. A plaster for treating mastitis of a milk goat is characterized by comprising the following raw materials in parts by weight: 10-12 parts of realgar, 50-55 parts of golden cypress, 5-6 parts of borneol, 22-24 parts of madder, 20-24 parts of rhubarb, 100 parts of dandelion, 20-24 parts of bletilla striata, 20-24 parts of keel, 20-22 parts of Japanese ampelopsis root, 10-12 parts of pseudo-ginseng, 35-38 parts of astragalus mongholicus and 75-80 parts of skin penetrant.
2. The plaster for treating mastitis in milk goats according to claim 1, wherein the skin penetrating agent is N-alkylbenzisothiazolinone.
3. The preparation method of the plaster for treating the mastitis of the milk goats according to claim 1, which is characterized by comprising the following steps:
firstly, weighing raw materials in parts by weight; cutting radix Rubiae, radix et rhizoma Rhei, herba Taraxaci, rhizoma Bletillae, radix Ampelopsis, Notoginseng radix and radix astragali into small segments, mashing, soaking in edible oil for three days, heating, controlling oil temperature at 220 deg.C until the surface of the medicinal materials turns black and the inner part is brown, removing residue, and keeping medicinal oil; grinding realgar, phellodendron and keel and sieving by a 100-mesh sieve for later use;
secondly, heating the medicinal oil to 320 ℃ of 310-; stopping heating, and stirring to cool the ointment to room temperature;
thirdly, soaking the obtained ointment in cold water for 3 days, and changing water for 2 times every day; taking out the soaked ointment, drying, re-melting, adding borneol and a skin penetrating agent, uniformly mixing to obtain an ointment, spreading the ointment on a paper cloth, namely a type I medicine area (1) and a type II medicine area (4), and cooling to obtain the plaster for treating the mastitis of the dairy goat.
4. The method for preparing a plaster for treating mastitis in a milk goat according to claim 3, wherein the edible oil is one of soybean oil, rapeseed oil and tea oil.
5. The method for preparing a plaster for treating mastitis in a milk goat according to claim 3, wherein the paper cloth is divided into type I and type II.
6. The preparation method of the plaster for treating the mastitis of the milk goats according to claim 5, wherein the preparation method comprises the following steps: the width of the upper top is 30 cm, the total height is 40 cm, the diameter and the length of the blank area (3) are 5 cm, and the width of the I-type viscose area (2) is 1 cm.
7. The preparation method of the plaster for treating the mastitis of the milk goats according to claim 5, wherein the preparation method comprises the following steps: the diameter is 5 cm, wherein the diameter of the type II drug zone (4) is 4 cm and the width of the type II viscose zone (5) is 1 cm.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111123546.2A CN113648376A (en) | 2021-09-24 | 2021-09-24 | Plaster for treating mastitis of dairy goat and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111123546.2A CN113648376A (en) | 2021-09-24 | 2021-09-24 | Plaster for treating mastitis of dairy goat and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113648376A true CN113648376A (en) | 2021-11-16 |
Family
ID=78494302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111123546.2A Pending CN113648376A (en) | 2021-09-24 | 2021-09-24 | Plaster for treating mastitis of dairy goat and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113648376A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101647959A (en) * | 2009-09-18 | 2010-02-17 | 天津诺康动物药业有限公司 | Traditional Chinese medicine composition for treating mastitis of milk cow and preparation method thereof |
-
2021
- 2021-09-24 CN CN202111123546.2A patent/CN113648376A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101647959A (en) * | 2009-09-18 | 2010-02-17 | 天津诺康动物药业有限公司 | Traditional Chinese medicine composition for treating mastitis of milk cow and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
王彩红: "中西医结合治疗奶山羊乳房炎", 《畜牧兽医科技信息》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104054872A (en) | Herbal tea and preparation method thereof | |
CN103405731A (en) | External unguent for treating scald and burn and preparation method thereof | |
CN113648376A (en) | Plaster for treating mastitis of dairy goat and preparation method thereof | |
CN103070951B (en) | Externally used medicinal composition for treating cattle mange and preparation method thereof | |
CN106236650B (en) | A kind of removing acnes and controlling oil cream and preparation method thereof | |
CN104888056B (en) | A kind of externally applied anti-inflammation, care composition product and preparation technology thereof | |
CN110882346A (en) | Tibetan medicine medicament and preparation method thereof | |
CN1748744B (en) | Chinese medicine for treating beri-beri and its producing method | |
CN104147434A (en) | Chinese herbal lotion for treating tinea pedis | |
CN114392312B (en) | Traditional Chinese medicine composition for preventing and treating postpartum diseases of dairy cows and enhancing immunity and preparation method thereof | |
CN112915152B (en) | Traditional Chinese medicine mask for treating rash related to tumor molecule targeted medicine and preparation method thereof | |
CN108042610B (en) | Safe dental implant restoration liquid and preparation method thereof | |
CN105412828A (en) | Traditional Chinese medicine ointment for nursing tendinitis and preparation method of traditional Chinese medicine ointment | |
CN105194216A (en) | Barbiers eliminating essence and preparation method of barbiers eliminating essence | |
CN103550550B (en) | Traditional Chinese medicine for treating phlegm and blood stasis type gall disease | |
CN105288320A (en) | Traditional Chinese medicine preparation for treatment of oral ulcer and preparation method and applications thereof | |
CN111905070A (en) | Traditional Chinese medicine antibacterial liquid for treating beriberi and preparation method thereof | |
CN115812966A (en) | Dandelion extract, betel nut buccal product and preparation method | |
CN104784493A (en) | Traditional Chinese medicine for treating pediatric dermatitis eczema and preparation method thereof | |
CN113384519A (en) | Formula and preparation method of chilblain cream | |
CN111773367A (en) | Compound preparation for treating animal skin diseases and preparation method thereof | |
CN104127659A (en) | Traditional Chinese medicine for treating chronic pharyngitis | |
CN103100023B (en) | External medicinal liquor for treating skin diseases and preparation method thereof | |
CN114288345A (en) | Medicine for treating burn and scald and its preparing method | |
CN104666617A (en) | Blood-pressure-lowering medicine for treating hypertension |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |